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Background and Significance
Type two diabetes mellitus (T2DM) is a chronic
metabolic disorder that has become increasingly
common in the United States and around the world.
Metabolic disorders such as T2DM and obesity are
known to have a chronic low grade inflammatory
tissue environment as well as an increase in
excess lipids. Current research suggests that a
tightly regulated oligoprotein complex known as the
NLRP3 inflammasome is highly activated in T2DM
and obesity. However, it is not well understood the
interplay between excess lipids and inflammation. A
key transcription factor that is known to have both
an inflammatory effect as well as an effect on lipid
metabolism is PPARγ. For this reason, we
attempted to determine if PPARγ had an effect on
the degree of pro-inflammatory cytokine release
such as IL-1β in the presence of excess lipids.

Methods
In an attempt to determine the interplay between
lipid metabolism and inflammation, we created a
myeloid specific PPARγ KO mouse model. WT or
indicated KO peritoneal macrophages (pMACs)
were isolated from mice and adhered to indicated
plates. To activate the inflammasome a lipid
cocktail, namely palmitate, and LPS were given to
active the inflammasome complex in pMACs.

Figure 5. Neutralization of IFNβ signaling
normalized IL-1 Levels. Blockade of IFNβ
signaling with the IFNAR1 antibody restored IL-1β
levels to WT levels.

Figure 6. rIFNβ sufficient to reproduce PPARγ
KO phenotype. rIFNβ given to WT cells
phenocopied mPPARγKO cells. IFNβ levels caused
a dose dependent decrease in IL-1β and had no
effect on TNFα.

The NLRP3 Inflammasome Activation

Figure 1. Schematic of lipotoxic inflammasome
activation with and without PPARγ.

Figure 3. mPPARγKO pMACs selective
depletes IL-1 levels. Loss of PPARγ from
activated macrophages led to a selective
reduction in IL-1 mRNA and protein (A-C).

Hypothesis
We hypothesized loss of PPARγ would be
protective by altering lipid metabolism in
macrophages.

Figure 2. mPPARγ KO mouse model.

Figure 7. Schematic of inflammasome with IFNβ
response..
Figure 4. Heightened production and
release of IFNβ signaling in mPPARγ KO
cells. RNA sequencing and qPCR revealed an
increase IFN-regulated genes (A-B), as well as
IFNβ levels (C-D).

Discussion
Myeloid specific loss of PPARγ leads to selective reduction of
IL-1β due to an effect on signal 1 of the inflammasome and
increased IFNβ. Further research should investigate how loss of
PPARγ leads to increased IFNβ. Also it is advantageous to
study how increased IFNβ leads to selective depletion of IL-1
levels.

